Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases

BACKGROUND: Abatacept is a selective T-cell costimulation modulator approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. Reports were recently published on hepatitis B virus reactivation (HBVr) in patients who were treated with abatacept. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingjing, Zhang, Xin, Geng, Xiaozhen, Shi, Juanjuan, Jia, Xiaoli, Dang, Shuangsuo, Wang, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092962/
https://www.ncbi.nlm.nih.gov/pubmed/35706497
http://dx.doi.org/10.1016/j.eclinm.2022.101425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092962/
https://www.ncbi.nlm.nih.gov/pubmed/35706497
http://dx.doi.org/10.1016/j.eclinm.2022.101425

Ejemplares similares